nLEPTIN AND RESISTIN AFFECT PCSK9 EXPRESSION VIA STAT3 INVOLVEMENT

被引：0
|
作者：
Macchi, Chiara [1 ]
Botta, Margherita [1 ]
Garzone, Mariantonietta [1 ]
Marchiano, Silvia [1 ]
Giorgio, Eleonora [1 ]
Corsini, Alberto [1 ]
Magni, Paolo [1 ]
Ferri, Nicola [2 ]
Ruscica, Massimiliano [1 ]
机构：
[1] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[2] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.234
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG113
引用
收藏
页码：E70 / E71
页数：2
相关论文
共 50 条
  • [1] LEPTIN AND RESISTIN AFFECT PCSK9 EXPRESSION: IN VITRO AND IN VIVO EVIDENCE
    Macchi, C.
    Botta, M.
    Marchiano, S.
    Dongiovanni, P.
    Valenti, L.
    Cicero, A.
    Magni, P.
    Corsini, A.
    Ferri, N.
    Ruscica, M.
    ATHEROSCLEROSIS, 2018, 275 : E18 - E18
  • [2] STAT3 INHIBITION INDUCES PCSK9 IN HEPATIC CELL LINE: POSSIBLE INVOLVEMENT IN HYPERTRIGLYCERIDEMIA ASSOCIATED WITH INSULIN RESISTANCE
    Ricci, C.
    Ruscica, M.
    Macchi, C.
    Magni, P.
    Corsini, A.
    Ferri, N.
    ATHEROSCLEROSIS, 2015, 241 (01) : E46 - E47
  • [3] PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia
    Rashid, Shirya
    Kastelein, John J. P.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (11) : 1567 - 1577
  • [4] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [5] PCSK9 Involvement in Aortic Valve Calcification
    Poggio, Paolo
    Songia, Paola
    Cavallotti, Laura
    Barbieri, Silvia S.
    Zanotti, Ilaria
    Arsenault, Benoit J.
    Valerio, Vincenza
    Ferri, Nicola
    Capoulade, Romain
    Camera, Marina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (24) : 3225 - 3227
  • [6] Pancreatic PCSK9 and its involvement in diabetes
    Kockx, Maaike
    Kritharides, Leonard
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S2018 - S2022
  • [7] Role of PCSK9 beyond liver involvement
    Cariou, Bertrand
    Si-Tayeb, Karim
    Le May, Cedric
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) : 155 - 161
  • [8] Inflammation stimulates the expression of PCSK9
    Feingold, Kenneth R.
    Moser, Arthur H.
    Shigenaga, Judy K.
    Patzek, Sophie M.
    Grunfeld, Carl
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 374 (02) : 341 - 344
  • [9] High glucose effects on PCSK9 expression in aortic VSMC: role of PCSK9 inhibitors
    Barale, C.
    Melchionda, E.
    Russo, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S421 - S421
  • [10] Relation of resistin to PCSK9 levels in CAD patients with varying degree of obesity
    Li, S.
    Xu, R. -X.
    Zhang, Y.
    Guo, Y. -L.
    Zhu, C. -G.
    Liu, G.
    Dong, Q.
    Li, J. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 923 - 923
12345